(Q35055198)

6 August 2017

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial (English)

1 reference

6 August 2017

phase I clinical trial

0 references

0 references

12

John R Mascola

1 reference

6 August 2017

13

Gary J Nabel

1 reference

6 August 2017

15

Barney S Graham

1 reference

6 August 2017

16

Julie E Ledgerwood

1 reference

6 August 2017

3

Mary E Enama

1 reference

6 August 2017

11

Richard A Koup

1 reference

6 August 2017

14

Nancy J Sullivan

1 reference

6 August 2017

6

Cynthia S Hendel

1 reference

6 August 2017

1

Uzma N Sarwar

1 reference

6 August 2017

2

Pamela Costner

1 reference

6 August 2017

4

Nina Berkowitz

1 reference

6 August 2017

9

Sabue Mulangu

1 reference

6 August 2017

7

Sandra Sitar

1 reference

6 August 2017

8

Sarah Plummer

1 reference

6 August 2017

Zonghui Hu

5

1 reference

6 August 2017

Robert T Bailer

series ordinal

10

1 reference

6 August 2017

VRC 206 Study Team

series ordinal

17

1 reference

6 August 2017

language of work or name

English

0 references

publication date

14 September 2014

1 reference

Journal of Infectious Diseases

6 August 2017

1 reference

6 August 2017

211

1 reference

6 August 2017

4

1 reference

6 August 2017

549-557

1 reference

Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Ebolavirus vaccines for humans and apes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Vaccine research efforts for filoviruses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Development of a preventive vaccine for Ebola virus infection in primates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Crystal structure of the matrix protein VP40 from Ebola virus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318920

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

8 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25225676

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25225676

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIU511

1 reference

6 August 2017

1 reference

6 August 2017

1 reference